Adenomatous Polyposis Coli
Welcome,         Profile    Billing    Logout  
 5 Companies   3 Products   3 Products   5 Mechanisms of Action   0 Trials   32 News 
  • ||||||||||  sirolimus / Generic mfg.
    Trial completion:  Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) -  Jan 28, 2019   
    P2,  N=4, Completed, 
    Recruiting --> Completed
  • ||||||||||  sirolimus / Generic mfg.
    Trial primary completion date:  Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) -  Jan 10, 2018   
    P2,  N=5, Recruiting, 
    Recruiting --> Completed Trial primary completion date: May 2018 --> Jan 2019
  • ||||||||||  sirolimus / Generic mfg.
    Trial initiation date:  Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) -  Jul 5, 2017   
    P2,  N=5, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2012 --> Jun 2017 Initiation date: May 2017 --> Sep 2017
  • ||||||||||  sirolimus / Generic mfg.
    New P2 trial:  Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) -  Mar 30, 2017   
    P2,  N=5, Recruiting, 
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  IPAA: Ileal Pouch-Anal Anastomosis Registry (clinicaltrials.gov) -  Mar 17, 2017   
    P=N/A,  N=936, Terminated, 
    Initiation date: May 2017 --> Sep 2017 N=1500 --> 936 | Recruiting --> Terminated | Trial primary completion date: Dec 2050 --> Mar 2017; Researchers leading this study have left BMC
  • ||||||||||  Trial completion:  Curcumin in Treating Patients With Familial Adenomatous Polyposis (clinicaltrials.gov) -  Dec 14, 2016   
    P2,  N=50, Completed, 
    N=1500 --> 936 | Recruiting --> Terminated | Trial primary completion date: Dec 2050 --> Mar 2017; Researchers leading this study have left BMC Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Curcumin in Treating Patients With Familial Adenomatous Polyposis (clinicaltrials.gov) -  Oct 19, 2016   
    P2,  N=50, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> Nov 2016
  • ||||||||||  Trial primary completion date:  NIPCON: Non-Invasive Prediction of Colorectal Neoplasia (clinicaltrials.gov) -  Sep 27, 2016   
    P=N/A,  N=2282, Terminated, 
    Trial primary completion date: Aug 2016 --> Nov 2016 Trial primary completion date: Nov 2017 --> Aug 2014
  • ||||||||||  Trial primary completion date:  NIPCON: Non-Invasive Prediction of Colorectal Neoplasia (clinicaltrials.gov) -  Apr 7, 2016   
    P=N/A,  N=2282, Terminated, 
    Trial primary completion date: Nov 2017 --> Aug 2014 Trial primary completion date: Nov 2015 --> Nov 2017
  • ||||||||||  Enrollment closed, Phase classification:  Curcumin in Treating Patients With Familial Adenomatous Polyposis (clinicaltrials.gov) -  Mar 3, 2016   
    P2,  N=50, Active, not recruiting, 
    Trial primary completion date: Nov 2015 --> Nov 2017 Recruiting --> Active, not recruiting | Phase classification: PN/A --> P2
  • ||||||||||  Trial primary completion date:  Curcumin in Treating Patients With Familial Adenomatous Polyposis (clinicaltrials.gov) -  Jun 11, 2015   
    P=N/A,  N=50, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Oct 2015 Trial primary completion date: Jun 2015 --> Jul 2016
  • ||||||||||  Trial termination, Trial primary completion date:  NIPCON: Non-Invasive Prediction of Colorectal Neoplasia (clinicaltrials.gov) -  Feb 9, 2015   
    P=N/A,  N=2282, Terminated, 
    N=140 --> 0 Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Nov 2015; Local PI did not submit annual renewal, still active in Detroit, not recruiting.
  • ||||||||||  sulindac / Generic mfg., erlotinib / Generic mfg.
    Enrollment closed:  FAPEST: A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients (clinicaltrials.gov) -  Jun 23, 2014   
    P2,  N=100, Active, not recruiting, 
    Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Nov 2015; Local PI did not submit annual renewal, still active in Detroit, not recruiting. Recruiting --> Active, not recruiting